ENTX
Entera BioBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The constructive case is that EB613 now has a more streamlined Phase 3 path, a single-tablet commercial formulation, and a near-term regulatory feedback checkpoint that could unlock late-2026 study initiation and a clearer 2H 2028 topline path [#PR-2026-03-04].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
As a low-coverage small-cap biotech with only loose same-sector comparators in the packet, ENTX remains vulnerable to sharp repricing if regulatory timing slips, financing needs re-emerge, or investors cannot benchmark the program cleanly against direct peers.
Momentum
91
Value
41
Sentiment
36
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.00 · Bull $1.90 · Bear $0.55
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-02 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $10.00
Why
Momentum91 · Δ7d -
Value41 · Δ7d +0.1
Sentiment36 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
91
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
36
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 91.3 / Value 41.1 / Sentiment 35.8
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$61.53M
Beta
1.86
Shares Out
45.86M
P/E (TTM) · Derived
-5.4
P/S (TTM)
654.58
P/FCF (TTM) · Derived
-8.35
Rev YoY
-100.0%
EPS YoY
+15.3%
Gross Margin
0.0%
Op Margin
-8729.0%
Net Debt
-$8.66M
Current Ratio
10.83
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology